EZH2 and diffuse large B-cell lymphoma: However, this prevalence of EZH2 mutations in FL and DLBCL patient populations from Study E7438-000-101 differs from published data likely due to patient enrichment to fill various EZH2 mutation-positive cohorts within the trial.